Methods and compositions for producing an adenovirus vector for use with multiple… Grant US-11826417-B2 United States of America 28 Nov 2023
Methods and compositions for producing an adenovirus vector for use with multiple… Grant US-11529408-B2 United States of America 20 Dec 2022
Methods and compositions for producing an adenovirus vector for use with multiple… Grant US-11504423-B2 United States of America 22 Nov 2022
Methods and compositions for producing an adenovirus vector for use with multiple… Grant US-11389521-B2 United States of America 19 Jul 2022
Breast cancer vaccines and methods of use thereof Grant US-11376316-B2 United States of America 05 Jul 2022
Methods and compositions for combination immunotherapy Grant US-11352642-B2 United States of America 07 Jun 2022
Sequential administration of a replication defective adenovirus vector in vaccination… Grant US-11344613-B2 United States of America 31 May 2022
Methods and compositions for combination immunotherapy Grant US-11149087-B2 United States of America 19 Oct 2021
Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola… Grant US-10695417-B2 United States of America 30 Jun 2020
Replication defective adenovirus vector in vaccination Grant US-10563224-B2 United States of America 18 Feb 2020
METHODS AND COMPOSITIONS FOR COMBINATION IMMUNOTHERAPY Application EP-3286213-A4 European Patent Office 26 Sep 2018
METHODS AND COMPOSITIONS FOR COMBINATION IMMUNOTHERAPY Application EP-3242940-A4 European Patent Office 13 Jun 2018
Replication defective adenovirus vector in vaccination Grant US-9605276-B2 United States of America 28 Mar 2017